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The function of the Aurora B kinase at centromeres and the central spindle is crucial for
chromosome segregation and cytokinesis, respectively. Herein, we have investigated the regula-
tion of human Aurora B by its complex partners inner centromere protein (INCENP) and survivin.
We found that overexpression of a catalytically inactive, dominant-negative mutant of Aurora B
impaired the localization of the entire Aurora B/INCENP/survivin complex to centromeres and
the central spindle and severely disturbed mitotic progression. Similar results were also observed
after depletion, by RNA interference, of either Aurora B, INCENP, or survivin. These data suggest
that Aurora B kinase activity and the formation of the Aurora B/INCENP/survivin complex both
contribute to its proper localization. Using recombinant proteins, we found that Aurora B kinase
activity was stimulated by INCENP and that the C-terminal region of INCENP was sufficient for
activation. Under identical assay conditions, survivin did not detectably influence kinase activity.
Human INCENP was a substrate of Aurora B and mass spectrometry identified three consecutive
residues (threonine 893, serine 894, and serine 895) containing at least two phosphorylation sites.
A nonphosphorylatable mutant (TSS893–895AAA) was a poor activator of Aurora B, demonstrat-
ing that INCENP phosphorylation is important for kinase activation.
INTRODUCTION
Aurora kinases are evolutionarily conserved enzymes that
regulate different aspects of cell division. Only a single Au-
rora kinase is present in Saccharomyces cerevisiae (Francisco et
al., 1994; Francisco and Chan, 1994) and Schizosaccharomyces
pombe (Petersen et al., 2001; Leverson et al., 2002). In contrast,
three distinct Aurora family members, termed Aurora A, B,
and C, have been described in metazoan organisms (Adams
et al., 2001a; Nigg, 2001; Shannon and Salmon, 2002). A-type
Aurora kinases localize to both centrosomes and spindle
microtubules (Kimura et al., 1997; Bischoff et al., 1998) and
have been implicated in spindle assembly (Dutertre et al.,
2002; Kufer et al., 2002; Tsai et al., 2003). The B-type Aurora
kinases are present at centromeres in prophase and meta-
phase, before they relocalize to the central spindle and the
midbody in anaphase and telophase (Bischoff et al., 1998;
Terada et al., 1998). The C-type Aurora kinases have so far
been identified only in mammals (Tseng et al., 1998; Kimura
et al., 1999). They are expressed primarily in testis and some
tumor cell lines, where they have been localized to spindle
poles.
Aurora B exists in a complex with at least two other
proteins, inner centromere protein (INCENP) and survivin
(Adams et al., 2000; Kaitna et al., 2000; Wheatley et al., 2001a).
Aurora B, INCENP, and survivin are so-called chromosomal
passenger proteins: they associate with inner centromere
regions during prophase, but subsequently relocalize to the
midzone of the central spindle and concentrate at the mid-
body (Adams et al., 2001a). INCENP has a modular organi-
zation, and domains required for chromosomal and cy-
toskeletal interactions have been delineated (Ainsztein et al.,
1998; Mackay et al., 1998; Wheatley et al., 2001b). Of partic-
ular interest, all metazoan INCENPs, as well as the INCENP
homolog of S. cerevisiae (Sli15p), share a highly conserved
motif near the C terminus, the so-called IN-box (INCENP
conserved box) (Adams et al., 2000, 2001b). Mice lacking
INCENP showed very early (32- to 64-cell stage) embryonic
lethality (Cutts et al., 1999), and RNA interference (RNAi)-
mediated down-regulation of INCENP in Caenorhabditis el-
egans and Drosophila produced severe mitotic defects (Kaitna
et al., 2000; Adams et al., 2001c). Similar defects were also
seen upon overexpression of a dominant-negative INCENP
mutant in vertebrate cells (Mackay et al., 1998). Thus, IN-
CENP is clearly essential for cell division.
Survivin has originally been proposed to exert an anti-
apoptotic function (hence its name; Li et al., 1998), but this
issue remains controversial (Reed, 2001; Silke and Vaux,
2001). Instead, several lines of evidence point to an impor-
tant role of survivin in the regulation of late mitotic events
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(Fraser et al., 1999; Uren et al., 1999, 2000; Speliotes et al.,
2000; Kallio et al., 2001). Depletion of C. elegans Aurora B
(AIR-2) and survivin (BIR-1) produced very similar pheno-
types, indicating that the two proteins interact genetically
(Speliotes et al., 2000). Survivin has also been shown to
interact with INCENP in yeast two-hybrid experiments and
in vitro binding assays, and a dominant-negative mutant of
INCENP disrupted the targeting of survivin to centromeres
(Wheatley et al., 2001a). Most recently, additional evidence
for a physical interaction between survivin and Aurora
B/INCENP has also been reported in S. cerevisiae (Cheese-
man et al., 2002) and Xenopus egg extracts (Bolton et al., 2002).
Herein, we provide evidence that INCENP and survivin
regulate human Aurora B at multiple levels. First, our data
suggest that Aurora B kinase activity as well as INCENP
and/or survivin contribute to the proper localization of the
complex. Second, we show that recombinant human Aurora
B is strongly activated upon binding of INCENP, whether or
not survivin is part of the complex. Remarkably, this activa-
tion results in the phosphorylation of an evolutionarily con-
served motif within the C-terminal IN-box of INCENP, and




HeLa S3 cells were grown in DMEM (Invitrogen, Carlsbad, CA)
supplemented with 10% fetal calf serum (Invitrogen) and 50 g/ml
each of streptomycin and penicillin (Invitrogen). T-Rex-U2OS cells
(Invitrogen), and their derivatives were maintained in the same
medium with the further addition of 50 g/ml hygromycin B
(Merck, Whitehouse Station, NJ). Sf-9 cells were grown in TC-100
medium (Invitrogen) supplemented with 10% fetal calf serum (In-
vitrogen) and 50 g/ml streptomycin and penicillin (Invitrogen).
Cloning and Mutagenesis
Wild-type and kinase-deficient (K106R) human Aurora B cDNAs
have been described previously (Meraldi et al., 2002). To produce
inducible cell lines expressing Aurora B-myc-His6, wild-type and
K106R cDNAs were subcloned into the pcDNA4/TO/myc-His
vector (Invitrogen). A human INCENP cDNA was obtained by
reverse transcription-polymerase chain reaction (PCR) by using
total RNA from HeLa S3 cells. The PCR product was introduced
into the pBluescript SK() vector and completely sequenced. For
baculoviral expression, Aurora B and full-length INCENP were
inserted into the transfer vector pUNI10 and then recombined
with pHI100-GST or pHI100-His according to published proce-
dures (Liu et al., 1998). Ala mutants of INCENP, 893A894A895A
(3A) and 893A894A895A900A (4A), were obtained by site-di-
rected mutagenesis using the QuikChange kit (Stratagene, La
Jolla, CA). INCENP mutants 822–919 (C3), 855–919 (C4), 878 –919
(C5), 822– 897 (C6), 822– 877 (C7), and 822– 892 (C8) were ampli-
fied by PCR and cloned for baculoviral expression into a modi-
fied pVL1393 vector (BD Biosciences PharMingen, San Diego,
CA), which provides an N-terminal GST-tag followed by a Pre-
Scission protease cleavage site.
Antibody Production
A rabbit antibody (C; rabbit 4777) was raised against a peptide
spanning the 15 C-terminal residues (NSRRVLPPSALQSVA) of Au-
rora B, coupled to keyhole limpet hemocyanin. Two rabbit anti-
INCENP antibodies were generated against His6-INCENP (231–
397) expressed in Escherichia coli (rabbits 55 and 56).
Cell Synchronization
Exponentially growing HeLa S3 cells were blocked for 14 h with
thymidine (final concentration 2 mM), washed three times with
phosphate-buffered saline (PBS), and incubated with fresh medium.
After 13 h, aphidicolin was added (final concentration 1.6 g/ml)
and the plates were incubated for an additional 13 h. Plates were
then washed three times with PBS and fresh medium was added.
(This moment was defined as time 0). Cells were collected every 2 h
thereafter. For arresting cells in prometaphase, nocodazole (final
concentration 500 ng/ml) was added 6 h after release of cells from
the thymidine/aphidicolin double block, and mitotic cells were
collected 6 h later.
Western Blotting and Immunoprecipitation
For Western blotting, cellular proteins were solubilized in 2  gel
sample buffer, boiled for 5 min, and resolved by SDS-PAGE. Pro-
teins were then transferred to nitrocellulose membranes, and these
were incubated with antibodies against the N (N: monoclonal anti-
body [mAb]; BD Biosciences PharMingen) or C terminus of Aurora
B (C), INCENP (56), survivin (Novus-Biological, Littleton, CO),
cyclin B (USB, Cleveland, OH) and -tubulin (Sigma-Aldrich, St.
Louis, MO), followed by horseradish peroxidase-conjugated goat
anti-rabbit or anti-mouse antibody. Immunoreactivity was visual-
ized by enhanced chemiluminescence. For immunoprecipitation,
cells were lysed on ice for 30 min in radioimmunoprecipitation
assay buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-40,
0.5% deoxycholate, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride
[PMSF], 1 g/ml leupeptin, 1 g/ml pepstatin, 1 g/ml aprotinin,
30 g/ml DNase, 30 g/ml RNase, 20 mM -glycerophosphate, 0.3
mM sodium vanadate) and sonicated for 20 s. The lysates were
incubated at 4°C with anti-Aurora B antibody and then with protein
A-Sepharose (Bio-Rad, Hercules, CA) for 1 h each. For immunopre-
cipitation of ectopically expressed Aurora B-myc, lysates were in-
cubated with anti-myc mAb (9E10) bound to protein G-Sepharose
for 1 h at 4°C. Samples were spun down and washed twice with
radioimmunoprecipitation assay buffer, once with 50 mM Tris-HCl,
pH 8.0, 0.4 M NaCl, 1% NP-40, 0.5% deoxycholate, 1 mM PMSF, 1
g/ml leupeptin, 1 g/ml pepstatin, 1 g/ml aprotinin and twice
with 10 mM Tris-buffer (10 mM Tris-HCl, pH7.5, 150 mM NaCl, 0.1
mM PMSF).
Purification of Recombinant Proteins
Recombinant baculoviruses coding for glutathione S-transferase
(GST)- or His-tagged Aurora B, INCENP, and survivin were gener-
ated using the BaculoGold kit (BD Biosciences PharMingen) and
used to infect Sf-9 insect cells, according to the manufacturer’s
protocol. To all complex formation between Aurora B, INCENP, and
survivin in vivo, insect cells were coinfected with the appropriate
viruses. After 48 h, infected cells were pelleted and lysed in lysis
buffer (50 mM Tris-HCl, pH 8.0, 0.4 M NaCl, 1% NP-40, 0.5%
deoxycholate, 1 mM PMSF, 1 g/ml leupeptin, 1 g/ml pepstatin,
1 g/ml aprotinin, 20 mM -glycerophosphate, 0.3 mM sodium
vanadate), followed by centrifugation. The supernatants were incu-
bated with glutathione-Sepharose beads for 1 h at 4°C. Beads were
washed twice with lysis buffer, once with 50 mM Tris-HCl, pH 8.0,
0.4 M NaCl, 0.1% NP-40, 1 mM PMSF, 1 g/ml leupeptin, 1 g/ml
pepstatin, 1 g/ml aprotinin, and once with 10 mM Tris-buffer.
Then, samples were analyzed by Western blotting and used for
kinase assays.
For in vitro complex formation (experiment shown in Figure 11, C
and D), recombinant GST-Aurora B was eluted with 20 mM gluta-
thione solution in 50 mM Tris-HCl, pH 8.0, and dialyzed for 2  1 h
against 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 1
mM dithiothreitol (DTT), 0.1 mM PMSF. Recombinant GST-IN-
CENP fragments were prepared as follows: proteins bound to glu-
tathione-Sepharose beads were washed with and resuspended in
cleavage buffer (50 mM Tris-HCl, pH 7.0, 150 mM NaCl, 1 mM
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EDTA, 1 mM DTT, 0.01% NP-40). Then, PreScission protease (Am-
ersham Biosciences, Piscataway, NJ) was added and the suspension
incubated overnight at 4°C. After centrifugation, a first supernatant
was collected. The beads were washed once again with cleavage
buffer and the second supernatant combined with the first. Aliquots
of purified Aurora B and INCENP proteins were frozen in liquid
nitrogen and stored at 80°C.
In Vitro Kinase Assays
Immunoprecipitated or recombinant kinases were included into a
20-l reaction containing 0.5 mg/ml histone H3 (or 1 mg/ml myelin
basic protein [MBP]), 50 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM
EGTA, 1 mM DTT, 5 mM NaF, 5 mM -glycerophosphate, 0.05 mM
sodium vanadate, 0.1 mM ATP, and 1 Ci of -[32P]ATP. After 20
min at 30°C, reactions were stopped by the addition of 5 l of 5 gel
sample buffer. Protein samples were separated by SDS-PAGE and
phosphate incorporation determined by PhosphorImager.
Short Interfering RNA (siRNA) Treatment
Transfection of T-Rex-U2OS or HeLa S3 cells with siRNA duplex
oligonucleotides were performed using oligofectAMINE (Invitro-
gen), as described previously (Elbashir et al., 2001). The siRNA
sequences used for targeting human Aurora B were (AA)CGAGAC-
CTATCGCCGCATC(GT), for human INCENP (AA)GAAGCAGAT-
TGAGCAGAAG(TT), and for human survivin (AA)GAATTAAC-
CCTTGGTGAAT(TT). In all experiments, a duplex targeting the
luciferase gene was used as a control (Elbashir et al., 2001).
Immunofluorescence Microscopy
T-Rex-U2OS or HeLa S3 cells grown on coverslips were fixed in 20
mM PIPES, pH 6.8, 0.2% Triton X-100, 1 mM MgCl2, 10 mM EGTA,
4% formaldehyde for 10 min at room temperature, and washed
three times with PBS. Cells were then incubated in 3% bovine serum
albumin/PBS with primary antibodies. These were used at the
following dilutions: anti-Aurora B (N; 1:1000); anti-INCENP (55;
1:1000); anti-survivin (1:1000; Santa Cruz Biotechnology, Santa
Cruz, CA); anti-CENP-B (1:1000; gift from W. Earnshaw, University
of Edinburgh, Edinburgh, Scotland); anti--tubulin (1:1000; Sigma-
Aldrich); anti-myc mAb (not diluted). Primary antibodies were
visualized using Texas-Red or Alexa green-conjugated secondary
antibodies (Molecular Probes, Eugene, OR), and DNA was counter-
stained with 4,6-diamidino-2-phenylindole (DAPI).
Mass Spectrometry
Coomassie-stained protein bands were in-gel digested by trypsin
(sequencing grade; Promega) (Shevchenko et al., 1996) and desalted
using homemade miniaturized reversed-phase columns (Gobom et
al., 1999). Matrix-assisted laser desorption ionization/time of flight
mass spectra were acquired on a Reflex III instrument (Bruker
Daltonik, Bremen, Germany) in negative ion reflector mode. As a
matrix, 2,5 dihydroxybenzoic acid (Bruker Daltonik) was used.
Mass spectra were searched for signals showing a mass difference of
80 mass units (phosphate group) by a self-developed software
script. Such phosphopeptide-candidates were submitted to post-
source decay fragment ion analysis (Hoffmann et al., 1999). Peptides
showing the typical losses of 98 mass units (phosphoric acid) and 80
mass units (phosphate group) were accepted as phosphopeptides.
For peptide sequencing by electrospray tandem mass spectrometry,
samples were filled into nano electrospray needles (Protana,
Odense, Denmark) and analyzed on a QTOF Ultima (Micromass,
Manchester, United Kingdom) quadrupole time-of-flight instru-
ment.
RESULTS
Analysis of Aurora B Function by a Dominant-
Negative Approach
To study the function and regulation of human Aurora B
kinase, we produced stably transformed T-Rex-U2OS cell
lines that allow the inducible expression of wild-type or
catalytically inactive mutant Aurora B (K106R) under tetra-
cycline control. After induction of the transgenes for 24 h,
both wild-type and K106R mutant Aurora B were expressed
to similar levels (Figure 1A). Using an anti-myc antibody
directed against the C-terminal myc epitope tag, both pro-
teins were then immunoprecipitated and assayed for kinase
activity. When isolated from nocodazole-arrested cells, wild-
type Aurora B readily phosphorylated histone H3 (Figure
1A) and MBP (our unpublished data), but only little activity
was associated with the kinase isolated from an asynchro-
nously growing cell population. As expected, the K106R
mutant displayed no kinase activity even when immunopre-
cipitated from nocodazole-treated cells (Figure 1A).
At the cellular level, the expression of the K106R mutant
produced a striking multinucleation phenotype (Figure 1C).
The frequency of multinucleation depended on the length of
expression of the transgene, and by 48 h this phenotype was
seen in 50–60% of all cells (Figure 1D). The remainder of the
cells divided normally, presumably reflecting differences in
expression levels. Almost no multinucleation was seen when
cells were not treated with tetracycline or induced to express
the wild-type Aurora B (Figure 1, C and D). Both wild-type
and K106R mutant Aurora B interacted with endogenous
INCENP, as demonstrated by coimmunoprecipitation ex-
periments (Figure 1B). These data confirm that the catalyti-
cally inactive Aurora B acts as a dominant-negative mutant
whose overexpression severely impairs mitotic progression
(Terada et al., 1998). In the cell line analyzed herein, most
mitotic cells harboring the dominant-negative Aurora B mu-
tant were found to be in prophase and prometaphase-like
states, whereas anaphase or telophase cells were difficult to
find.
In parallel to the multinucleation phenotype, we also
observed an impaired localization of the catalytically in-
active Aurora B. Whereas the ectopically expressed wild-
type Aurora B showed the expected relocalization from
centromeres (Figure 2A) to the central spindle (Figure 2B),
the K106R mutant Aurora B frequently failed to localize
properly to either centromeres or the spindle midzone
(Figure 2). Few, if any, of the prometaphase cells express-
ing mutant Aurora B showed centromere staining (Figure
2A). Cells at later stages of mitosis (anaphase/telophase)
were difficult to find, because the expression of mutant
Aurora B severely impaired mitotic progression, but in
these cases, mutant Aurora B showed no, or at most faint,
association with spindle structures (Figure 2B). As sug-
gested in recent studies (Murata-Hori and Wang, 2002;
Murata-Hori et al., 2002), inactive Aurora B may localize
transiently to chromosomes and spindle structures. How-
ever, in the mitotic cells analyzed herein, the bulk of the
mutant protein seemed to be distributed diffusely, indi-
cating that proper localization of Aurora B to centromeres,
the central spindle and the midbody requires kinase ac-
tivity. Finally, in some cells expressing only low amounts
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of mutant Aurora B, the protein displayed (near-) normal
localization (our unpublished data). These latter cells
showed no evidence of mitotic aberration.
To determine whether INCENP and survivin also de-
pended on Aurora B activity for proper localization, the cells
expressing the K106R mutant were stained with antibodies
directed against INCENP or survivin. Although the kineto-
chore marker CENP-B localized properly, neither INCENP
nor survivin could be detected at centromeres (Figure 3).
These data suggest that catalytically inactive Aurora B se-
questers both INCENP and survivin and prevents their as-
sociation with centromeres. The expression of wild-type Au-
rora B did not interfere with INCENP or survivin
localization (our unpublished data).
Figure 1. A catalytically inactive Au-
rora B acts as a dominant-negative
mutant. (A) Inducible T-Rex U2OS cell
lines (Invitrogen) harboring myc-
tagged K106R mutant or wild-type
(wt) human Aurora B transgenes were
treated with or without tetracycline (1
g/ml final concentration). After 8 h,
nocodazole (or dimethyl sulfoxide)
was added and cells were incubated
for an additional 16 h. Myc-tagged
Aurora B was immunoprecipitated
with anti-myc antibody, and protein
amounts and kinase activities in im-
munoprecipitates were determined by
Western blotting (top) and in vitro ki-
nase assays (bottom). (B) Myc-tagged
K106R or wild-type Aurora B were
immunoprecipitated with anti-myc
antibody from lysates used in A. Im-
munoprecipitates were subjected to
Western blotting with antibodies
against myc-Aurora B and INCENP;
whole-cell lysates were analyzed in
parallel. (C) K106R and wild-type Au-
rora B expressing cells were treated
for 24 h with or without tetracycline
and then analyzed by immunofluores-
cence microscopy with anti-myc anti-
bodies. DNA was counterstained with
DAPI. (D) Histogram shows a quanti-
tative analysis of the extent of
multinucleation at different times of
wild-type or K106R mutant Aurora B
expression.
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Figure 2. Mislocalization of the K106R Aurora B mutant in mitosis.
T-Rex U2OS cell lines expressing myc-tagged Aurora B wild-type
and K106R mutant were fixed 24 h after induction and subjected to
immunofluorescence microscopy, by using the anti-myc antibody.
DNA was counterstained with DAPI. (A) prometaphase (B) an-
aphase and telophase stages. Red, myc; blue, DAPI.
Figure 3. Localization of INCENP and survivin in cells expressing
the K106R mutant of Aurora B. T-Rex U2OS cell lines expressing
myc-tagged K106R mutant Aurora B were incubated for 10 h in the
presence or absence of tetracycline, fixed and then stained with
antibodies against INCENP, survivin, or CENP-B (green). DNA was
counterstained with DAPI (blue). Prometaphase stage cells are
shown.
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Figure 4.
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Disruption of the Aurora B/INCENP/Survivin
Complex by RNAi
To better understand the mutual influence of Aurora B,
INCENP, and survivin on the assembly and localization of
the kinase complex, we targeted all three proteins by siRNA
(Elbashir et al., 2001). Experiments were performed on U2OS
(Figures 4 and 5) and HeLa S3 cells (our unpublished data),
with similar results. Two distinct antibodies were used to
monitor the levels of Aurora B (Figure 4A). One antibody,
directed against the N terminus of Aurora B, produced a
closely spaced doublet band of the expected size (Figure 4A,
lane 3), but the second antibody, raised against the C termi-
nus, also recognized an additional protein of lower molec-
ular weight (Figure 4A, lanes 1 and 2). Western blotting after
siRNA treatment of cells with a duplex targeting Aurora B
revealed that the levels of both proteins decreased in parallel
(Figure 4B), suggesting that the smaller immunoreactive
protein represents either a cleavage product or a splice
variant of Aurora B. The physiological role, if any, of this
protein is not presently clear.
Interestingly, both Aurora B and INCENP showed an
electrophoretic retardation in M phase samples (Figure 4A).
Many kinases are activated by phosphorylation of a threo-
nine residue within the so-called T-loop (or activation loop),
and this seems to be true also for Aurora family members
(Walter et al., 2000; Murnion et al., 2001; Chen and Tang,
Figure 5. Lack of centromere localization of Aurora B/INCENP/survivin after depletion of individual proteins by siRNA. After treatment
of T-Rex-U2OS cells for 48 h by siRNA duplexes directed against Aurora B, INCENP, or survivin, all three proteins were localized by
immunofluorescence microscopy. DNA was counterstained with DAPI.
Figure 4 (facing page). Depletion of INCENP or survivin by
siRNA results in mitotic defects and multinucleation. (A) Aurora B
and INCENP protein levels in asynchronously growing (lane 1) or
nocodazole treated (lanes 2 and 3) HeLa S3 cell extracts. To detect
the Aurora B protein by Western blotting, two distinct antibodies
were used, one directed against the C terminus (lanes 1 and 2), the
other against the N terminus (lane 3). (B) Aurora B, INCENP,
surviving, and -tubulin levels after 48 h treatment with siRNA
directed to Aurora B, INCENP, or survivin, as indicated. The GL-2
duplex was used for control. (C) Depletion of INCENP or survivin
caused multinucleation. U2OS cells were fixed 48 h after siRNA
treatment and stained with anti--tubulin antibodies (green). DNA
was counterstained with DAPI (blue). (D) Mitotic defects in IN-
CENP- or survivin-depleted cells, 48 h after treatment with siRNA.
-Tubulin staining: red; DNA staining: blue.
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2002; Littlepage et al., 2002). The relevant residue in Aurora
B, T232, is located within a motif that fits the emerging
consensus for Aurora B phosphorylation sites (see below),
suggesting that the observed upshift could result from au-
tophosphorylation of the T-loop. The shift in INCENP is also
likely to reflect phosphorylation, as inferred from previous
studies on the Xenopus homolog (Stukenberg et al., 1997;
Bolton et al., 2002). In the case of survivin, no evidence for
cell cycle dependent alterations in gel electrophoretic mobil-
ity could be observed (our unpublished data; Figure 6).
Depletion of any one subunit of the Aurora B/INCENP/
survivin complex by siRNA caused a substantial reduction
not only in the corresponding target but also in the two other
subunits, albeit to a variable extent (Figure 4B). The abun-
dance of -tubulin was not reduced, attesting to the speci-
ficity of these effects (Figure 4B). At the cellular level, a
phenotype was observed that was very similar to that seen
after overexpression of the K106R Aurora B mutant in
T-Rex-U2OS cells. Beginning at 24 h and prominent by 48 h
after transfection with siRNA duplexes most interphase cells
displayed multiple nuclei and/or micronuclei (Figure 4C).
Mitotic cells showed mainly prometaphase-like phenotypes,
with apparent defects in both chromosome congression and
spindle morphology (Figure 4D). Anaphase and telophase
stages were also abnormal, frequently showing lagging
chromosomes (Figure 4D). In addition, a significant number
of apoptotic cells were seen (our unpublished data). Results
were qualitatively similar regardless of which subunit was
Figure 6. Cell cycle analysis of Aurora B,
INCENP, and survivin. (A) Aurora B, IN-
CENP, survivin, cyclin B, and -tubulin pro-
tein levels through the cell cycle were deter-
mined by Western blotting. HeLa S3 cells
were synchronized by an arrest-release pro-
tocol from an aphidicolin/thymidine block at
the G1/S boundary (time 0). For comparison,
cells were also analyzed after a nocodazole
induced prometaphase arrest (noc). Arrows
point to the full-length, wild-type Aurora B,
whereas the arrowhead and asterisk denote
the slower migrating form of INCENP. (B)
Aurora B kinase activity at the corresponding
cell cycle stages was measured in immuno-
precipitates, by using histone H3 as a sub-
strate, and analyzed using a PhosphorImager
(bottom). Amounts of immunoprecipitated
Aurora B protein were determined by West-
ern blotting (top). A sample of the nocoda-
zole-treated cell lysate before immunopre-
cipitation [lys(noc)] was analyzed in parallel.
The numbers indicate the relative specific ac-
tivity of Aurora B, with the value at the 4-h
time point arbitrarily set to 1.0.
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targeted by siRNA, but the phenotypes seen after depletion
of Aurora B were less pronounced than those seen after
depletion of INCENP and survivin. This may reflect a lower
efficiency of the Aurora B siRNA treatment.
Immunofluorescent staining of mitotic cells revealed that
the depletion of any one of the components of the Aurora
B/INCENP/survivin complex by siRNA abolished the cen-
tromere association of all three proteins (Figure 5). Taken at
face value, this suggests that the formation of the entire
Aurora B/INCENP/survivin complex is required for effi-
cient localization, confirming and extending previous stud-
ies from C. elegans (Speliotes et al., 2000) and Drosophila
(Adams et al., 2001c). However, this interpretation is com-
plicated by the observed reduction in protein levels of the
entire complex (Figure 4B; see DISCUSSION).
Cell Cycle Regulation of the Aurora B Kinase
Complex
To examine the regulation of Aurora B activity during the
cell cycle, HeLa S3 cells were synchronized and Aurora B,
INCENP and survivin protein levels determined by Western
blotting; in parallel, Aurora B kinase activity was measured
in immunoprecipitates (Figure 6). Aurora B, INCENP, and
survivin protein levels showed very similar changes during
cell cycle progression, whereas -tubulin levels, analyzed as
a loading control, were constant. All three subunits of the
Aurora B complex were low in G1/S, increased during G2
and M, and then declined. In comparison, cyclin B1 accu-
mulated with similar kinetics but then disappeared earlier
and more abruptly (Figure 6A), suggesting that it is de-
graded before Aurora B.
Maximal Aurora B kinase activity was observed in immu-
noprecipitates prepared from M phase samples, at 10–12 h
after release from the G1/S block (Figure 6B). At this time
point, the specific activity of Aurora B was nearly twice as
high as that measured at the 4- to 8-h time points, indicating
that the cell cycle-dependent increase in protein abundance
was not sufficient to explain the rather abrupt activation of
Aurora B. Instead, we emphasize that at the 10-h time point
a population of INCENP with a reduced electrophoretic
mobility became apparent (Figure 6; see also Figure 4A).
This mobility shift of INCENP occurred at about the same
time as Aurora B activation, raising the possibility that IN-
CENP-modification could contribute to Aurora B activation.
Role of INCENP and Survivin in the Activation of
Aurora B
To examine the role of INCENP and survivin in Aurora B
activation, Aurora B kinase complexes were reconstituted,
using the baculovirus expression system. The three proteins
were coexpressed in various combinations in Sf-9 insect
cells, and complexes were then purified through an N-ter-
minal GST-tag on Aurora B. As shown in Figure 7, Aurora B
formed binary complexes with both INCENP and survivin.
When all three subunits were coexpressed, both INCENP
and survivin copurified with GST-Aurora B (Figure 7, right).
We presume that this reflects formation of a ternary complex
but cannot rigorously exclude a mixture of two binary com-
plexes. Determination of kinase activities associated with
these complexes, by using MBP as an exogenous substrate,
revealed that INCENP caused a 7- to 10-fold activation of
Aurora B, whereas survivin produced no detectable effect
(Figure 7). We have not been able to accurately determine
the stoichiometry of these complexes but emphasize that no
influence of survivin on Aurora B activity could be detected
over a wide range of survivin/Aurora B ratios (our unpub-
lished data).
We have also examined the ability of INCENP to activate
Aurora B with regard to histone H3, a purported physiolog-
ical substrate of this kinase. Again, the Aurora B/INCENP
complex was much more active than Aurora B alone (Figure
8). Furthermore, both INCENP and Aurora B became phos-
phorylated in these reactions. This indicates that INCENP is
both an activator and a substrate of Aurora B. To determine
which domains within INCENP were important for Aurora
B activation, a series of INCENP deletion mutants was pro-
duced (Figure 9A). These mutants were then assayed for
their ability to bind to Aurora B, to be phosphorylated by
Aurora B, and to activate Aurora B (Figure 9B). Because
Aurora B had previously been reported to bind to the C-
terminal region of INCENP in other species (Kaitna et al.,
2000), our analysis was focused on the C-terminal domain of
INCENP. Initial experiments revealed that both the C1 (587–
919) and the C2 (785–919) fragments were able to bind and
activate Aurora B as well as to serve as substrates (our
unpublished data). Thus, smaller fragments, C3-C8, were
Figure 7. Effects of INCENP and survivin on Aurora B kinase
activity. GST-Aurora B, GST-Aurora B/His-survivin, GST-Aurora
B/His-INCENP, and GST-Aurora B/His-survivin/His-INCENP
complexes were coexpressed in Sf-9 cells and purified using gluta-
thione-Sepharose. Aurora B protein levels were determined by
Western blotting, and kinase activity was measured in in vitro
kinase assays, with or without MBP as an exogenous substrate.
Phosphate incorporation was analyzed using a PhosphorImager.
INCENP and survivin copurifying with Aurora B were also de-
tected by Western blotting. MBP was visualized by Coomassie Blue
staining (CBB).
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analyzed (Figure 9, A and B). C3 (822–919), which lacks the
predicted coiled-coil region but contains the IN-box, bound
to and activated Aurora B, and this fragment was also phos-
phorylated efficiently. In contrast, fragments C4 (855–919)
and C5 (878–919) produced only weak and marginal activa-
tion, presumably because both mutants showed only weak
binding to Aurora B. Fragments C6 (822–897), C7 (822–877),
and C8 (822–892) all interacted with Aurora B to a similar
extent, but C7 was unable to confer kinase activation. These
data allow the following conclusions to be drawn. First,
because the C3 mutant activated Aurora B as efficiently as
full-length INCENP, the coiled-coil region (residues 520–
800) does not seem to be necessary for activation. Second,
because C7 was unable to activate Aurora B, although it
bound as efficiently as C6 and C8, a domain of 15 residues
(878–892) is required for Aurora B activation.
Phosphorylation of INCENP Enhances Aurora B
Activity
In a next series of experiments, we sought to identify the
Aurora B phosphorylation site(s) in the C terminus of
INCENP. To this end, phosphorylated C2 (785–919) and C3
(822–919) were analyzed by mass spectrometry (Figure 10).
Both fragments contained a single phosphopeptide,
TSSAVWNSPPLQGAR (893–907). The doubly phosphory-
lated species of this peptide was the most abundant one,
although a minor component containing three phosphates
could also be detected (Figure 10). Fragmentation analysis
led us to conclude that at least two residues within the TSS
motif were phosphorylated, but we could not determine the
exact sites. In line with these results, the INCENP fragments
containing the TSS motif (C3 and C6) were phosphorylated
by Aurora B, whereas those lacking the motif (C7 and C8)
were not (Figure 9B). To further confirm the above-men-
tioned mass spectrometry data, point mutations were intro-
duced at T893, S894, S895, and S900. Mutated C3 fragments
with three (3A; T893A, S894A, and S895A) or four (4A;
T893A, S894A, S895A, and S900A) residues changed to ala-
nine still bound to Aurora B (Figure 11A), but they were not
phosphorylated to any significant extent (Figure 11B). No
differences could be observed between the 3A and 4A mu-
tants, confirming that Aurora B phosphorylates the C-termi-
nal region of INCENP primarily on the three residues mak-
ing up the TSS motif.
To determine whether phosphorylation by Aurora B in-
fluences INCENP function, we compared the ability of wild-
type and triple Ala mutant versions (3A) of both C3 (Figure
11) and full-length INCENP (Figure 12) to activate Aurora B.
Kinase assays were performed on Aurora B/INCENP com-
plexes that had either been formed in Sf-9 cells in vivo
(Figures 11, A and B, and 12), or reconstituted from recom-
binant proteins in vitro (Figure 11, C and D). In all cases, the
3A mutants were much less effective in Aurora B activation
than wild-type versions of INCENP. These data indicate that
the phosphorylation of TSS by Aurora B enhances the ability
of INCENP to activate Aurora B. However, as shown in
Figure 9B, the mutant C8 (which lacks the TSS motif) was
nearly as efficient in activating Aurora B as C6 (which con-
tains the motif and hence can be phosphorylated). This
indicates that deletion of the INCENP C terminus (898–919)
produces a similar effect as TSS phosphorylation. We con-
clude that maximal activation of Aurora B by wild-type
INCENP requires the phosphorylation of the TSS motif, but
that this requirement is alleviated upon removal of the ex-
treme C terminus of INCENP.
When the TSS motif was altered to AAA, phosphorylation
of the C-terminal fragment C3 by Aurora B was virtually
abolished (Figure 11). In contrast, a full-length INCENP
bearing these mutations was still phosphorylated by Aurora
B, albeit to a lesser extent, whereas no phosphorylation
could be seen upon coexpression of INCENP with the cata-
lytically inactive Aurora B mutant, ruling out contamination
by insect cell kinases (Figure 12B). This indicates that Aurora
B phosphorylates INCENP also outside the C-terminal do-
main.
In an attempt to test the role of INCENP phosphorylation
on the TSS motif in human cells, we have transiently trans-
fected full-length wild-type and 3A-mutant INCENP into
HeLa S3 and U2OS cells (our unpublished data). We found
that both proteins localized primarily to the nucleus, al-
though, at high expression levels, they also produced micro-
tubule bundling in the cytoplasm. In mitotic cells, both
proteins still localized to prometaphase centromeres and the
midbody. No adverse effects could be observed on either the
localization of endogenous Aurora B or mitotic progression.
Although we cannot exclude subtle phenotypes (e.g., an
increased rate of chromosome missegregation), these data
Figure 8. Phosphorylation of INCENP by Aurora B. GST-Aurora B
and GST-Aurora B/His-INCENP complexes were purified using
glutathione-Sepharose, and Aurora B protein levels were deter-
mined by Western blotting (left). The complexes were then used for
in vitro kinase reactions, with or without histone H3 as an exoge-
nous substrate. Phosphate incorporation was detected using a Phos-
phorImager (right, top) and histone H3 visualized by CBB (bottom).
Note the incorporation of phosphate into both INCENP and Aurora
B (arrows).
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indicate that the 3A mutant INCENP did not exert a domi-
nant negative effect. In control experiments, overexpression
of an INCENP mutant comprising the N-terminal domain
(residues 1–290) severely impaired cell division and caused
frequent DNA bridges, consistent with previous results
(Mackay et al., 1998).
Figure 9. Mapping of INCENP domains required for activation of Aurora B. (A) Schematic representation of INCENP deletion mutants
(C1–C8). The amino acid sequences of deletion mutants C3–C8 are indicated using the single-letter code. The regions of INCENP involved
in Aurora B binding (822–877) and activation (878–892), as well as the domain serving as a substrate for phosphorylation (893–919), were
deduced from the data shown in B. (B) The GST-INCENP deletion mutants (C3–C8) were coexpressed with His-Aurora B in Sf-9 cells and
isolated on glutathione-Sepharose beads. The GST-INCENP mutants and coprecipitating His-Aurora B were then detected by Western
blotting with anti-GST and anti-Aurora B antibodies, respectively. Phosphorylation of the INCENP mutants and histone H3 kinase activity
of all samples were tested in parallel.
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Figure 10. Identification of major phosphor-
ylation sites within INCENP by mass spec-
trometry. Matrix-assisted laser desorption
ionization/time of flight mass spectrum of a
tryptic digest of the INCENP C2 fragment
(785–919) phosphorylated by Aurora B in
vitro. A selected mass range containing the
unphosphorylated (0 ph), singly (1 ph), dou-
bly (2 ph), and triply phosphorylated (3 ph)
peptide (893–907) TSSAVWNSPPLQGAR is
shown. The identity and phosphorylation
states of these peptides were confirmed using
postsource decay analysis and electrospray
tandem mass spectrometry (our unpublished
data) as described in MATERIALS AND
METHODS. The spectrum was recorded in
negative ion reflector mode using 2,5 dihy-
droxybenzoic acid as matrix.
Figure 11. Ala mutants of INCENP C3 frag-
ment are less effective in Aurora B activation.
(A) The GST-INCENP mutants C7, C3,
C3(3A), or C3(4A) and His-Aurora B were
coexpressed in Sf-9 cells and the complexes
purified as described in the legend to Figure
9. INCENP and Aurora B protein levels were
determined by Western blotting. (B) Kinase
activities associated with the samples de-
scribed in A were measured with or without
exogenous histone H3; the bottom panel
shows a prolonged exposure to illustrate
phosphorylation of GST-INCENP fragments.
(C) GST-Aurora B and INCENP C3 (WT or
3A) were purified separately, and after mix-
ing of the proteins, phosphorylation of IN-
CENP was assayed (top); the presence of
equal amounts of INCENP substrate was
demonstrated by Coomassie Blue staining
(CBB; bottom). (D) The effect of adding in-
creasing amounts of INCENP C3 (WT or 3A)
to Aurora B was measured by in vitro kinase
assays, with histone H3 (top) or MBP (bot-
tom) as substrates.
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INCENP Phosphorylation and Aurora B Consensus
Sites
The region flanking the TSS motif is highly conserved
among INCENP proteins from various species, with the
notable exception of Sli15p from budding yeast. As shown in
Figure 13, the TSS motif is conserved among vertebrates,
whereas invertebrates (D. melanogaster and C. elegans) fea-
ture a SS motif. Furthermore, in all these species the
INCENP phosphoacceptor sites are preceded by two basic
amino acids (KR), suggesting that basic residues contribute
to a consensus motif defining Aurora B substrates. Indeed,
several presumed substrates of Aurora B, including histone
H3 (Hsu et al., 2000; Adams et al., 2001c; Giet and Glover,
2001; Goto et al., 2002; Sugiyama et al., 2002) and CENP-A
(Zeitlin et al., 2001), contain similar phosphoacceptor sites,
and putative autophosphorylation sites within the activation
loop of Aurora B also conform to this consensus.
DISCUSSION
The B-type Aurora kinases are critical regulators of chromo-
some segregation and cytokinesis in organisms ranging from
yeast to human. They are implicated in regulating chromo-
some structure and cohesion, kinetochore–microtubule inter-
actions, microtubule dynamics, the spindle checkpoint, and
mitotic exit (Shannon and Salmon, 2002). Yet, our understand-
ing of the regulation of these kinases remains incomplete and
several critical substrates probably await identification. Herein,
we have investigated the consequences of overexpressing
wild-type and catalytically inactive Aurora B in human cells
and examined the effects of depleting Aurora B and its complex
partners INCENP and survivin by siRNA. Furthermore, we
have studied the expression and activity of Aurora B kinase
during the human cell cycle and obtained evidence for an
involvement of posttranslational mechanisms in kinase activa-
tion. Aurora B complexes with INCENP and survivin were
then reconstituted from recombinant baculoviruses and sub-
jected to biochemical analyses. These studies, and the use of
mass spectrometry, have revealed an evolutionarily conserved
mechanism for Aurora B activation by INCENP binding and
phosphorylation.
Probing Aurora B Function by siRNA and
Dominant-Negative Approaches
Our functional studies confirm the notion that Aurora B is
critical for multiple aspects of mitotic progression. Expres-
sion of the kinase-deficient mutant exerted a dominant-
negative effect and resulted in a terminal phenotype charac-
terized by multinucleation, in agreement with previous
findings (Terada et al., 1998; Tatsuka et al., 1998). The mo-
lecular mechanisms leading to this phenotype remain to be
completely understood, but we emphasize that most mitotic
cells showed either a prometaphase-like state with poorly
aligned chromosomes or an aberrant anaphase state charac-
terized by lagging chromosomes (Figure 2B). This points to
both a chromosome congression defect and the lack of a
functional spindle assembly checkpoint, in agreement with
recent studies performed in other species (Biggins and Mur-
ray, 2001; Adams et al., 2001c; Kallio et al., 2002; Murata-Hori
and Wang, 2002; Tanaka et al., 2002).
Figure 12. INCENP phosphorylation and Aurora B activation. (A)
Full-length INCENP with mutated TSS motif barely activates Au-
rora B. Complexes of Aurora B and either wild-type or 3A mutant
full-length INCENP were formed in Sf-9 cells and purified using
glutathione-Sepharose beads. Recovery of proteins was determined
by Western blotting (top and middle) and kinase activity of the
complexes measured using histone H3 as a substrate (bottom). Lane
1, GST-INCENP (3A)/His-Aurora B; lane 2, GST-INCENP (WT)/
His-Aurora B; lane 3, His-INCENP (3A)/GST-Aurora B; and lane 4,
His-INCENP (WT)/GST-Aurora B. (B) Residual phosphorylation of
INCENP with mutated TSS motif. Phosphate incorporation into IN-
CENP was tested by subjecting Aurora B/INCENP complexes to in
vitro kinase reactions. Protein levels of Aurora B and INCENP were
determined by Western blotting, and the kinase activity of each com-
plex was measured with histone H3 as substrates. Lane 1, GST-Aurora
B(WT)/His-INCENP(WT); lane 2, GST-Aurora B(WT)/His-
INCENP(3A); and lane 3, GST-Aurora B(K106R)/His-INCENP(3A).
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Our results suggest that both Aurora B kinase activity and
the formation of the Aurora B/INCENP/survivin complex
contribute to its proper localization. Recently, Murata-Hori
and Wang reported that a green fluorescent protein-tagged
version of a catalytically inactive Aurora B showed at least
partial localization to centromeres and central spindles (Mu-
rata-Hori and Wang, 2002; Murata-Hori et al., 2002). In our
stable cell lines, we also observed (near-) correct localization
of mutant Aurora B in those cells that expressed low
amounts of this protein. In the majority of cells, however, the
catalytically inactive Aurora B did not efficiently localize to
either the centromere or the midzone, presumably due to
higher expression levels (Figure 2B). Thus, it is plausible that
mutant Aurora B may localize correctly at low expression
levels, but mislocalize at higher levels. Endogenous
INCENP and survivin also failed to localize properly in the
presence of mutant Aurora B (Figure 3). Thus, phosphory-
lation of an as yet unidentified Aurora B substrate seems
to be essential for efficient association of the Aurora B/
INCENP/survivin complex with the centromere.
We also observed that depletion of any one subunit of the
Aurora B/INCENP/survivin complex by siRNA abolished
centromere-staining by antibodies against all three compo-
nents (Figure 5). The most straightforward interpretation of
this result is that all three subunits are required for correct
localization of the complex, in line with results from previ-
ous RNAi studies in C. elegans (Speliotes et al., 2000) and
Drosophila (Adams et al., 2001c) and a recent antisense ex-
periments in human cells (Chen et al., 2002). However, be-
cause depletion of Aurora B, INCENP or survivin reduced
the levels of all three components of the complex (Figure 4),
one could also argue that all three subunits are required for
stability, rather than localization, of the complex. This is
difficult to exclude, but we favor an explanation for the data
in Figure 4B that takes into account the terminal phenotype
produced by these siRNA experiments. Depletion of any one
subunit in fact produces multinucleated cells in G1 phase
(Figure 4C) in which the three subunits of the Aurora B
complex are known to be low (Figure 6).
Cell Cycle Regulation of the Aurora B Complex
Our analysis of the expression of Aurora B, INCENP, and
survivin during the human cell cycle revealed that all three
subunits are coordinately expressed, with lowest levels in
G1, followed by steady increases toward the onset of mito-
sis. Thus, the abundance of INCENP and survivin is unlikely
to limit the activity of Aurora B in human cells. At the G2/M
transition, Aurora B kinase activity increased sharply, and
concomitantly, INCENP became modified. This suggested
that modification of INCENP could conceivably contribute
to the activation of the complex. Previous studies have iden-
tified Xenopus INCENP as a candidate substrate of Cdk1
(Stukenberg et al., 1997), but the functional consequences of
INCENP phosphorylation by Cdk1 are not known. In this
study, we demonstrate that phosphorylation of human IN-
CENP by Aurora B contributes to the activation of the com-
plex (see below).
Reconstitution of Active Aurora B Complexes in Sf-
9 Insect Cells
To further study the roles of INCENP and survivin in the
activation of Aurora B, recombinant proteins were ex-
pressed from baculoviruses in insect cells. Both INCENP
and survivin were able to bind Aurora B. However, survivin
was unable to confer kinase activation, regardless of
whether or not INCENP was present in the complex. This
result contrasts with a recent report that survivin activates
Aurora B through binding to its catalytic domain (Chen et
al., 2002). We cannot presently explain this discrepancy, but
note that another study implicates the noncatalytic, regula-
tory domain of Aurora B in survivin binding (Bolton et al.,
2002). Our in vitro data suggest that survivin regulates other
aspects of Aurora B function, although they do not exclude
a contribution to the regulation of catalytic activity in vivo.
In complexes isolated from Xenopus egg extracts, Aurora B
activity could be modulated by removal and back-addition
of survivin (Bolton et al., 2002). However, simple binding of
survivin is unlikely to account for cell cycle-dependent dif-
ferences in Aurora B activity, because interphasic and mi-
totic Aurora B complexes contained similar amounts of sur-
vivin (Bolton et al., 2002).
Most interestingly, binding of INCENP strongly stimu-
lated Aurora B activity, regardless of whether complexes
were allowed to form within Sf-9 cells in vivo or reconsti-
tuted from purified recombinant proteins in vitro. Thus, a
binary complex of human Aurora B and INCENP displays
activity, confirming and extending results obtained for yeast
and invertebrate complexes (Kang et al., 2001; Bishop and
Schumacher, 2002). By analyzing a series of INCENP dele-
tion mutants, we identified a C-terminal domain (residues
822–892) as the minimal region required for Aurora B acti-
vation. This region overlaps with the IN-box proposed pre-
viously to comprise a binding domain for Aurora B kinases
(Adams et al., 2001a; Leverson et al., 2002). However, our
present mapping data refine our understanding of this in-
teraction domain. In particular, whereas residues 822–877
were required for complex formation with Aurora B, resi-
dues 878–892 were critical for activation but, interestingly,
not required for binding.
Concomitant with activation of Aurora B, strong phos-
phorylation of INCENP was observed. By mass spectrome-
try, a tripeptide (TSS: T893, S894, and S895) located within
Figure 13. Aurora B phosphorylation sites
in INCENP. The C termini of INCENP pro-
teins of all listed species, except for budding
yeast, show a highly conserved phosphoryla-
tion motif. This motif conforms to an emerg-
ing consensus motif for Aurora B phosphor-
ylation sites (see text).
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the C-terminal IN-box was identified as the major site of
phosphorylation. These results contribute to define a con-
sensus motif for Aurora B phosphorylation sites (Figure 13).
Mutation of the three TSS residues to alanines (3A) substan-
tially reduced the ability of both full-length INCENP and a
C-terminal INCENP fragment (C3) to activate Aurora B. To
test the role of TSS phosphorylation in vivo, we transiently
expressed both wild-type and 3A-INCENP in human cells.
These assays failed to reveal a striking dominant-negative
effect associated with the 3A-INCENP mutant, but it would
be premature to exclude subtle phenotypes. It is possible
that the 3A-INCENP mutant could not be expressed to suf-
ficient levels to interfere with endogenous wild-type
INCENP. Alternatively, the 3A-INCENP mutant may still
confer sufficient activation to Aurora B to permit function-
ality (Figure 12). Although the regulatory influence of IN-
CENP phosphorylation may be difficult to demonstrate by
overexpression studies, this modification is likely to be crit-
ical for Aurora B function at physiological protein levels.
While this manuscript was in preparation, phosphoryla-
tion of the C terminus of INCENP (ICP-1) was reported to
stimulate Aurora B (AIR-2) activity in C. elegans (Bishop and
Schumacher, 2002). Our present results are in excellent
agreement with this report, and the phosphorylation sites
identified by mass spectrometry in human INCENP match
the sites inferred from site-directed mutagenesis in C. elegans
ICP-1. However, it is noteworthy that vertebrates contain
three phosphorylatable residues, whereas Drosophila and C.
elegans only contain two (see alignment in Figure 13). To-
gether, the studies performed on human INCENP and C.
elegans ICP-1 concur to demonstrate that phosphorylation of
a conserved motif within the IN-box represents an evolu-
tionarily conserved mechanism for activation of the Aurora
B kinase.
Our data suggest a two-step model for the activation of
Aurora B by INCENP. They indicate that INCENP binding
first stimulates the activity of Aurora B, but that phosphor-
ylation of INCENP is then required for full activation of the
complex. In support of this view, a C-terminal INCENP
fragment lacking the TSS motif was a fairly powerful acti-
vator of Aurora B (Figure 9), suggesting that phosphoryla-
tion of the TSS motif is primarily required to change the
position or conformation of the IN-box in such a way as to
confer maximal activity to the complex. It will be interesting
to see whether this model is borne out by future structural
analyses of Aurora B/INCENP complexes.
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